Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lungwena Antenatal Intervention Study
NCT00131235Phase 3Active, not recruiting
- Sponsor
- Tampere University
- Start
- Dec 2003
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sulfadoxine + pyrimethamine and azithromycin in malaria, sexually transmitted diseases (STD) and preterm birth (3 arms), sponsored by Tampere University. Primary endpoints: Proportion of preterm births and Number of serious adverse events. Started Dec 2003; status: active, not recruiting.
02
Drugs
sulfadoxine + pyrimethamineazithromycin
03
Conditions
malariasexually transmitted diseases (STD)preterm birth
Beyond the preview
Go deeper on NCT00131235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131235.